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Objectives: to compare the exposure of plasma proteins adsorbed onto three vascular graft materials (polytetrafluoroethylene
ePTFE and two modifications of polyethyleneterephthalate Dacron).
Methods: surface exposure of fibronectin, vitronectin, thrombospondin, antithrombin III, IgG, high molecular-weight
kininogen, fibrinogen, albumin and plasminogen was studied by incubation with radiolabelled antibodies in a perfusion
model. Perfusion times with human plasma were 1, 4, 24 and 48 hours.
Results: all proteins could be detected at 1, 4, 24 and 48 hours after the start of perfusion. Overall, the least amount of
proteins adsorbed onto ePTFE.
Conclusions: the low adsorption of proteins onto ePTFE may be one of the reasons for the lower incidence of infections
reported with this material.
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Introduction effect.7 The kinetics and sequence of exchange, and
hence the composition of the adsorbate, varies with
In modern vascular surgery, the commercially avail- the type of polymer surface.8 Postadsorptional changes
able materials polyethyleneterephthalate (Dacron) and of configuration of the adsorbed proteins may be of
expanded polytetrafluoroethylene (ePTFE) are the vital importance for their functions, and are influenced
most frequently used materials. The most serious com- by the properties of the biomaterial.9–11
plications regarding the use of biomaterials in the Adsorbed proteins such as fibronectin, fibrinogen
vascular system are thrombus formation and bacterial and thrombospondin interact with various cell surface
infections.1,2 events and have been proposed to mediate adhesion
Within seconds after implantation into the body, of bacteria to implanted biomaterial surfaces.12–14 Even
host proteins and glycosaminoglycans adsorb onto the if adsorbed proteins may mediate bacterial binding
biomaterial surface. The molecules adsorb to a varying in vitro, serum or whole-blood components tend to
extent depending on characteristics of the biomaterial, decrease bacterial adhesion to biomaterials when com-
such as charge, rigidity, ultrastructure and surface pared to non-pretreated materials.15,16 Bacteria be-
hydrophobicity, but also on the composition of the longing to the normal skin flora, such as the coagulase-
host fluid and if the biomaterial is exposed to the host negative staphylococci (CNS) are frequently found as
fluid under perfusion or static conditions.3–6 When a aetiological agents in biomaterial-associated infections.
graft surface is exposed to flowing plasma, protein Staphylococcus aureus, Gram-negative bacilli and Can-
exchange reactions will occur at its surface. Initially dida albicans have also been isolated from infections
low molecular-weight molecules such as albumin dom- related to inserted grafts. Microbes may colonise the
inate quantitatively, but are at later stages replaced by biomaterial surface by receptor-specific interaction
high molecular-weight molecules with higher surface with domains on the adsorbed proteins, or by non-
affinities such as immunoglobulin, fibronectin, fib- specific mechanisms directly to the surface.17
rinogen and other molecules, the so-called Vroman This study was undertaken to elucidate the exposure
of adsorbed proteins and exchange reactions that occur
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in high-flow velocity perfusion model. The initial ad-
sorption to surfaces with different properties, as well
as later postadsorptional changes of configuration,
leads to exposure of different domains of the adsorbed
proteins. This may influence subsequent cell surface
events like binding of other host proteins, microbes,
and eukaryotic cells, and interact with various
biological systems such as complement and platelet
activation, and cytokine and growth factor produc-
tion.18,19
Materials and Methods Fig. 1. Principles of the perfusion model. From the pump, there is
a unidirectional flow at 1220 ml/min, velocity inside column of
0.04 m/s. The reservoir is kept in warm water and continuouslyThe commercially available vascular graft materials
monitored to 37 °C. The graft material is inserted into the columnpolyethyleneterephthalate, i.e. Dacron, and poly- that is connected to the silicone tubes with latex fittings. The system
tetrafluoroethylene, i.e. ePTFE, were used in our in vitro is sterilised perfusing ethanol for 30 min followed by 3 litres of
sterile water prior to insertion of the graft material.study. Two different Dacron fabrics, knitted, gelatin-
impregnated (GelsoftÒ, Vascutek Limited, Ayr, Scot-
land) and woven, non-impregnated (ULPÒ, Inter- of approximately 4.1 cm/s and at a temperature of
+37 °C (Fig. 1). A high flow velocity was used tovascular, Inc., LaCiotat, France) Dacron. Only one
ePTFE material was selected for the study (Gore-TexÒ mimic the naturally high flow conditions in human
vessels. The Reynolds index (NR) was determined tostandard, W. L. Gore & Associates, Inc., Flagstaff, AZ,
U.S.A.). The outer diameters of Dacron grafts were 9 833, allowing laminar flow (NR<2000). The membrane
pump was a KNF Flodos (type ND 100 TT.18) with aand 10 mm, respectively, and that of ePTFE was 10 mm.
Human plasma was purchased from the Blood Bank, flow capacity of 1220 ml/minute. The column in which
the graft was held is a Pharmacia K25 (inner diameterLund University Hospital, prior to experiments and
kept at +4 °C until use. The plasma was diluted 1:2 25 mm, length 410 mm). The graft was held in place
inside the column by four sutures.with 0.06 M phosphate buffered saline (PBS), pH 7.2
and 0.15% (w/v) sodium azide was added to prevent The graft material was perfused with diluted plasma
for 1, 4, 24 and 48 h and subsequently extirpated. Aftermicrobial growth. The plasma was cultured at the
beginning and the end of each experiment with regard extirpation, the graft was rinsed three times in one
piece with PBS for 10 min each time. The graft wasto microbial growth, using incubation of plasma onto
blood agar (incubation aerobically for 48 h at+37 °C). cut into 2-mm pieces and put in glass tubes prior to
detection with specific primary antibodies. The specificNo bacteria were found in the cultures. Approximately
175 ml of plasma were used in each experiment. primary antibodies were directed against the human
plasma proteins anti-thrombin III, fibrinogen, fibro-Primary specific antibodies (antibodies to anti-
thrombin III, fibrinogen, IgG, albumin, fibronectin, nectin, IgG, albumin, vitronectin, plasminogen, throm-
bospondin and high molecular-weight kininogen andplasminogen) were all purchased from DAKO
Immunoglobulins A/S, Copenhagen, Denmark. Anti- diluted 1:100 in PBS with 1% bovine serum albumin
(BSA); totally 2 ml was added to each tube. The graftbodies against high molecular-weight kininogen were
purchased from The Binding Site, Birmingham, U.K. samples were incubated for 4 h under gentle agitation
in room temperature. The samples were then rinsedAntibodies to human thrombospondin and vitronectin
were raised in rabbits in our laboratory. Secondary three times as above and blocked in PBS with 1% BSA
for 1 h, to prevent unspecific binding and rinsed threeantibodies, rabbit anti-mouse, swine anti-rabbit and
rabbit anti-sheep were also purchased from DAKO times in PBS again. Radiolabelled (125iodine) secondary
antibodies, diluted 1:100 in PBS with 1% BSA, wereImmunoglobulins A/S. Na125 iodine was from Amer-
sham Laboratories, Little Chalfont, Buckinghamshire, used to determine the extent of protein adsorption on
the surface of the material. The graft samples wereU.K., and IodobeadsÌ for iodination was from Pierce
Chemicals Co, Rockford, IL, U.S.A. rinsed three times as above and transferred to plastic
tubes. The radioactivity was detected by a gamma-We used the perfusion model, earlier developed by
Yu et al.20 and modified by Lundberg et al.,21 where the counter (LKB-Wallac 2772, Turku, Finland). The extent
of adsorption of each protein was expressed as thegraft was exposed to flowing human plasma at a rate
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percentage of total added radioactivity. The amount the end of the experiment, but the levels of albumin on
knitted gelatin-impregnated Dacron did not decreaseof radioactivity was correlated to the dry weight of
each graft piece as earlier described by Lundberg et (Fig. 2C and D).
al.22,23 Non-perfused as well as perfused graft materials
were used as controls. Controls were used in all the
Discussionexperiments for the secondary antibodies and the
amount of radioactivity found on control grafts was
The use of radiolabelled antibodies provides in-subtracted from that of the perfused graft pieces every
formation about which proteins are exposed on theperfusion time. Each graft material was perfused at
surface of the graft material. The polyclonal primaryleast twice for each perfusion time, to get a minimum
antibodies used were less sensitive to postadsorptionalof eight samples for protein detection. Knitted, gelatin-
changes of adsorbed proteins than monoclonals. Thus,impregnated Dacron was perfused twice giving a total
qualitative differences in exposure of adsorbed pro-of eight to nine samples, woven Dacron was perfused
teins between different materials may escape ex-three times giving 11–13 samples, and ePTFE was
amination. The secondary antibodies were radio-perfused twice giving eight to 13 samples for each
labelled, which enabled quantitative determination ofprotein detection and perfusion time.
protein exposure on the surface. However, the extentData were expressed as median values due to a
of protein exposure must not be compared betweennon-parametric distribution. The Kruskal–Wallis non-
different proteins, due to different affinity de-parametric ANOVA analysis was performed to in-
terminants of the antibodies. Exposure of one proteinvestigate if there were significant differences between
on different surfaces or at different time intervals canthe graft materials, i.e. that the curves are statistically
be compared, as shown. The antibodies which wereseparate, and is shown above every perfusion time in
used to determine the extent of exposition of adsorbedthe graphs. We then used the Mann–Whitney non-
proteins only bind to the outermost layer of proteins.parametric test to differentiate between which of the
The composition of the underlying protein layer re-three materials the significant differences existed and
mains unknown. However, it is the outermost layerthis is presented in Table 1. A p-value <0.05 was
of proteins that is most likely to be involved in surface-considered significant.
associated events. The data presented provide in-
formation about protein exposure at various points of
time.
The importance of the present study is explainedResults
by the fact that adsorbed proteins expose biologically
active domains. Host proteins adsorb to the biomaterialThe results from the study are presented fully in
graphical form (Fig. 2(A–I)) and only briefly in text. surfaces within seconds after exposure to the flowing
plasma and these proteins will subsequently influenceAll proteins observed showed a fast initial adsorption,
within 1–4 h, and then remained fairly unchanged up a number of biological functions, such as platelet
activation, complement activation,21 eukaryotic cell ad-to 48 h. The proteins were all present at 48 h and most
did not show any sign of disappearing with time. The hesion,24 clot formation18 and microbial adhesion5,12,14,25
by interaction with different domains on the exposedePTFE graft material had the lowest adsorption of
anti-thrombin III, fibrinogen, fibronectin, vitronectin, proteins. Proteins adsorb differently from a complex
protein solution than from a buffer solution and theIgG, high molecular-weight kininogen and throm-
bospondin compared to the other two graft materials importance of studies with human plasma must be
emphasised.6 The plasma used in our experiments(Fig. 2A, B, C, E, F, H and I). Using antibodies against
plasminogen and albumin, no such difference could came from several donors each perfusion time and the
accurate concentrations of the individual proteins inbe detected between the three materials (Fig. 2D and
G). The ePTFE surface always expressed its peak value plasma remain unknown. Here, a perfusion model
with a high flow velocity was used to mimic theof protein adsorption at 4 h for all proteins observed.
Anti-thrombin III accumulated on knitted, gelatin- perfusion conditions in vivo. A difference is that the
pump did not provide a pulsatile flow, which existsimpregnated Dacron at the end of the detection period,
i.e. 48 h (Fig. 2A and G). The level of exposure of in the blood circulation. This model allowed detection
of proteins on both the internal and the external surfacefibrinogen, fibronectin, vitronectin and plasminogen
remained fairly constant throughout the experiment of the graft.
The sequence of protein-exchange reactions oc-(Fig. 2B, E, F and G). On ePTFE and woven Dacron
graft materials, IgG and albumin decreased towards curring on solid surfaces in contact with human plasma
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Table 1. Non-parametric ANOVA and Mann–Whitney statistics.
Timepoint and ANOVA Sign. Between which Mann–Whitney Sign.
protein non-parametric level materials do the non-parametric level
p-value differences exist? p-value
Non-perfused
IgG 0.0380 * Vascutek vs. PTFE 0.0079 **
Pl 0.0004 *** Vascutek vs. PTFE 0.0002 ***
Vascutek vs. ULP <0.0001 ***
Tsp 0.0061 ** Vascutek vs. PTFE <0.0001 ***
HMWK 0.0006 *** Vascutek vs. PTFE 0.0079 **
ULP vs. PTFE <0.0001 ***
1-h Perfusion
AT-III 0.0255 * Vascutek vs. PTFE <0.0001 ***
Fg 0.0086 ** Vascutek vs. PTFE <0.0001 ***
IgG <0.0001 *** Vascutek vs. PTFE 0.0435 *
Vascutek vs. ULP <0.0001 ***
ULP vs. PTFE <0.0001 ***
Alb 0.0030 ** Vascutek vs. ULP 0.0012 **
ULP vs. PTFE 0.0479 *
Fn 0.0007 *** Vascutek vs. PTFE <0.0001 ***
Vascutek vs. ULP 0.0409 *
ULP vs. PTFE 0.0227 *
Vn 0.0177 * Vascutek vs. PTFE 0.0400 *
ULP vs. PTFE 0.0117 *
Pl 0.0008 *** Vascutek vs. PTFE 0.0078 **
Vascutek vs. ULP 0.0252 *
ULP vs. PTFE 0.0016 **
Tsp 0.0033 ** Vascutek vs. ULP 0.0012 **
ULP vs. PTFE 0.0074 **
HMWK <0.0001 *** Vascutek vs. PTFE <0.0001 ***
Vascutek vs. ULP 0.0102 *
ULP vs. PTFE <0.0001 ***
4-h Perfusion
AT-III 0.0055 ** Vascutek vs. PTFE 0.0274 *
ULP vs. PTFE 0.0024 **
Fg <0.0001 *** Vascutek vs. PTFE <0.0001 ***
Vascutek vs. ULP 0.0004 ***
ULP vs. PTFE 0.0095 **
IgG <0.0001 *** Vascutek vs. PTFE <0.0001 ***
ULP vs. PTFE <0.0001 ***
Alb <0.0003 *** Vascutek vs. PTFE 0.0002 ***
ULP vs. PTFE 0.0004 ***
4-h Perfusion
Fn <0.0001 *** Vascutek vs. PTFE <0.0001 ***
Vascutek vs. ULP <0.0001 ***
ULP vs. PTFE 0.0016 **
Vn <0.0006 *** Vascutek vs. ULP 0.0124 *
ULP vs. PTFE <0.0001 ***
24-h Perfusion
IgG 0.0018 ** ULP vs. PTFE <0.0001 ***
Fn 0.0074 ** Vascutek vs. PTFE 0.0002 ***
Vn 0.0344 * ULP vs. PTFE 0.0030 **
HMWK 0.0046 ** ULP vs. PTFE <0.0001 ***
Tsp 0.0092 ** Vascutek vs. PTFE 0.0070 **
Vascutek vs. ULP 0.0070 **
48-h Perfusion
AT-III <0.0001 *** Vascutek vs. PTFE <0.0001 ***
Vascutek vs. ULP 0.0071 **
ULP vs. PTFE <0.0001 ***
Fg <0.0001 *** Vascutek vs. PTFE <0.0001 ***
ULP vs. PTFE <0.0001 ***
IgG <0.0001 *** Vascutek vs. PTFE 0.0011 **
Vascutek vs. ULP <0.0001 ***
ULP vs. PTFE <0.0001 ***
continued
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Table 1. continued.
Timepoint and ANOVA Sign. Between which Mann–Whitney Sign.
protein non-parametric level materials do the non-parametric level
p-value differences exist? p-value
Alb 0.0075 ** Vascutek vs. PTFE 0.0043 **
Vascutek vs. ULP 0.0056 **
Fn <0.0001 *** Vascutek vs. PTFE <0.0001 ***
Vascutek vs. ULP 0.0033 **
ULP vs. PTFE <0.0001 ***
Vn <0.0001 *** Vascutek vs. PTFE 0.0024 **
ULP vs. PTFE <0.0001 ***
Tsp <0.0001 *** Vascutek vs. PTFE 0.0007 ***
ULP vs. PTFE <0.0001 ***
HMWK <0.0001 *** Vascutek vs. PTFE <0.0001 ***
ULP vs. PTFE <0.0001 ***
was first described by Vroman and Adams.7 Factors Surface area differences between ePTFE and the two
types of Dacron materials may account for some ofsuch as the diffusion constants of the protein molecules
are important in early stages of adsorption, since the the differences in protein exposure and adsorption.
The ePTFE material has a microporous structure andsmall molecules reach the solid surface first. At later
stages molecules which have higher surface affinity is relatively non-porous compared to the multi-
filamented Dacron graft fabric. The porous nature ofwill replace the molecules that first arrived to the
surface. Thus, competition and exchange of protein knitted grafts increases the fibre surface area available
for protein adsorption and may contribute to the dif-molecules are the two mechanisms that are mixed
with each other and stated to be of most importance.10 ferences between the various materials. The GelsoftÒ
material is impregnated with gelatin (zero porosity).The Vroman effect is best studied on hydrophilic sur-
faces and the protein sequence proposed is albumin– This would result in a larger available surface area as
the gelatin diminishes over time. The disappearanceIgG–fibronectin–fibrinogen–high-molecular-weight kin-
inogen. With increasing hydrophobicity of the of gelatin might be responsible for the stable and
increased levels of protein exposition from 1 to 48materials, i.e. Dacron and ePTFE, the strength of pro-
tein interactions increases and the exchange reactions hours. The chemical structure of ePTFE grafts, with
its increased hydrophobicity compared to Dacron, canwill differ or may not even take place.9
The exposure of albumin and IgG on knitted gelatin- also contribute to the differences in protein exposition.
The highest degree of protein exposition was, for mostimpregnated and woven Dacron was decreasing with
time, which is consistent with the Vroman effect or proteins, seen on knitted, gelatin-impregnated Dacron
and may be attributed to the increased hydrophilicityformation of a protein layer.26 Proteins with a high
affinity for foreign surfaces, such as fibronectin, some- of the gelatin-impregnated surface. The Vroman effect
may be of importance only within the first hour oftimes accumulated on the surface, after long-time per-
fusion with plasma, according to the Vroman effect.7 perfusion with the current perfusion fluid, plasma
diluted 1:2. The curves do not show variations in aSuch increase in exposition of fibronectin was, how-
ever, not verified in this study. Both Dacron materials way comparable with the Vroman hypothesis. It is
most likely that protein–protein interactions give riseshowed higher variations of protein exposure than
ePTFE. Of the three materials studied, ePTFE turned to protein layers instead of or acting simultaneously
with protein exchange events.26out to have the lowest protein adsorption, most evident
for fibronectin, fibrinogen, vitronectin, thrombo- Staphylococcus aureus is known to express binding
to fibrinogen, through several cell-wall structures27spondin, anti-thrombin III, high molecular-weight
kininogen and IgG. Furthermore, ePTFE showed no, and the binding to immobilised fibrinogen is important
for adhesion of S. aureus even under perfusion con-or sparse, increase in protein exposure with time, as
was seen on the other two surfaces, GelsoftÒ and ULPÒ. ditions.28 Fibronectin is another molecule which
Fig. 2. (A–I) Detection of exposed plasma proteins on the three different graft materials. Knitted, gelatin-impregnated Dacron (O),
woven Dacron (E) and ePTFE (M) were investigated. Quantitation was made using radiolabelled antibodies. Results (median value of
duplicate samples of two–three experiments) are expressed as percentage bound antibodies (cpm/mg) of total added antibody. The
presented p-values are ANOVA statistics and signify that the curves are statistically separate from each other. p<0.05 *, p<0.01 ** and
p<0.001 ***.
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